Jeppe Tang Friborg

Jeppe Tang Friborg is a Clinical Associate Professor at the Department of Clinical Medicine, specializing in Clinical Oncology at the University of Copenhagen. His work is focused on head and neck cancer treatment and research, with particular expertise in radiation therapy and clinical trials. He is actively involved in several major research projects including the DAHANCA 35 trial comparing proton therapy versus photon therapy for head and neck cancer.

Dr. Friborg's research primarily centers on improving cancer treatment outcomes, particularly for head and neck cancer patients. His work spans multiple areas including radiation therapy optimization, proton therapy applications, management of radiation-induced side effects, and clinical trial design. He has made significant contributions to understanding factors affecting patient participation in clinical trials, developing risk prediction models for cancer recurrence, and evaluating novel therapeutic approaches such as immunotherapy and stem cell therapy for radiation complications.

His recent publications (2024-2025) demonstrate a strong focus on head and neck cancer research, with particular emphasis on proton therapy applications, radiation toxicities, and innovative treatment approaches. The articles show a consistent pattern of clinical trial involvement, comparative effectiveness research, and efforts to improve patient outcomes through precision oncology approaches. His work often involves international collaborations and population-based studies to generate robust evidence for clinical practice.

Dr. Friborg is actively involved in mentoring and supervising research projects, as evidenced by his numerous collaborative publications with junior researchers and colleagues. While specific grant information isn't detailed in the available text, his extensive publication record in high-impact journals suggests successful grant acquisition to support his research endeavors in radiation oncology and head and neck cancer treatment.

His research appears to be conducted within the context of the DAHANCA (Danish Head and Neck Cancer) research group, which conducts clinical trials and observational studies focused on improving outcomes for head and neck cancer patients in Denmark. This collaborative team includes medical physicists, radiation oncologists, surgeons, and other specialists working together to advance cancer care.